{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:04:00Z","timestamp":1779671040549,"version":"3.53.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004008","name":"Istituto Superiore di Sanit\u00e0","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004008","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-48093-2","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T05:05:57Z","timestamp":1775797557000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tear fluid as a novel specimen for detection of alpha-synuclein seeding activity in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Matteo","family":"Costanzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ladogana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sbriccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Porreca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Salciccia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Equestre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Moracci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Ilenia","family":"De Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Ruocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Carlo","family":"Carl\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fabbrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Belvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Poleggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"48093_CR1","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","volume":"30","author":"RB Postuma","year":"2015","unstructured":"Postuma, R. B. et al. MDS clinical diagnostic criteria for Parkinson\u2019s disease: MDS-PD Clinical Diagnostic Criteria. Mov. Disord. 30, 1591\u20131601 (2015).","journal-title":"Mov. Disord"},{"key":"48093_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"48093_CR3","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson, D. W. et al. Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol. 8, 1150\u20131157 (2009).","journal-title":"Lancet Neurol."},{"key":"48093_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrn1007","volume":"4","author":"C Soto","year":"2003","unstructured":"Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4, 49\u201360 (2003).","journal-title":"Nat. Rev. Neurosci."},{"key":"48093_CR5","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41593-018-0235-9","volume":"21","author":"C Soto","year":"2018","unstructured":"Soto, C. & Pritzkow, S. Protein misfolding, aggregation, and conformational strains in neurodegenerative diseases. Nat. Neurosci. 21, 1332\u20131340 (2018).","journal-title":"Nat. Neurosci."},{"key":"48093_CR6","doi-asserted-by":"publisher","first-page":"105997","DOI":"10.1016\/j.neubiorev.2024.105997","volume":"169","author":"C Salciccia","year":"2025","unstructured":"Salciccia, C. et al. Proteopathic seed amplification assays in easily accessible specimens for human synucleinopathies, tauopathies, and prionopathies: A scoping review. Neurosci. Biobehavioral Reviews. 169, 105997 (2025).","journal-title":"Neurosci. Biobehavioral Reviews"},{"key":"48093_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41531-021-00232-4","volume":"7","author":"C Quadalti","year":"2021","unstructured":"Quadalti, C. et al. Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. npj Parkinsons Dis. 7, 93 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"48093_CR8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1038\/s41591-023-02358-9","volume":"29","author":"A Okuzumi","year":"2023","unstructured":"Okuzumi, A. et al. Propagative \u03b1-synuclein seeds as serum biomarkers for synucleinopathies. Nat. Med. 29, 1448\u20131455 (2023).","journal-title":"Nat. Med."},{"key":"48093_CR9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s41531-021-00242-2","volume":"7","author":"A Kuzkina","year":"2021","unstructured":"Kuzkina, A. et al. Diagnostic value of skin RT-QuIC in Parkinson\u2019s disease: a two-laboratory study. npj Parkinsons Dis. 7, 99 (2021).","journal-title":"npj Parkinsons Dis."},{"key":"48093_CR10","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1002\/mds.28242","volume":"35","author":"S Manne","year":"2020","unstructured":"Manne, S. et al. Blinded RT-QuIC Analysis of \u03b1-Synuclein Biomarker in Skin Tissue From Parkinson\u2019s Disease Patients. Mov. Disord. 35, 2230\u20132239 (2020).","journal-title":"Mov. Disord."},{"key":"48093_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/mds.29246","volume":"38","author":"G Vivacqua","year":"2023","unstructured":"Vivacqua, G. et al. Salivary \u03b1-Synuclein RT\u2010QuIC Correlates with Disease Severity in de novo Parkinson\u2019s Disease. Mov. Disord. 38, 153\u2013155 (2023).","journal-title":"Mov. Disord."},{"key":"48093_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S1474-4422(25)00157-7","volume":"24","author":"CD Orr\u00fa","year":"2025","unstructured":"Orr\u00fa, C. D. et al. Diagnostic and prognostic value of \u03b1-synuclein seed amplification assay kinetic measures in Parkinson\u2019s disease: a longitudinal cohort study. Lancet Neurol. 24, 580\u2013590 (2025).","journal-title":"Lancet Neurol."},{"key":"48093_CR13","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40035-022-00311-3","volume":"11","author":"M Bongianni","year":"2022","unstructured":"Bongianni, M. et al. Olfactory swab sampling optimization for \u03b1-synuclein aggregate detection in patients with Parkinson\u2019s disease. Transl Neurodegener. 11, 37 (2022).","journal-title":"Transl Neurodegener"},{"key":"48093_CR14","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1002\/mds.28976","volume":"37","author":"M Luan","year":"2022","unstructured":"Luan, M. et al. Diagnostic Value of Salivary Real-Time Quaking\u2010Induced Conversion in Parkinson\u2019s Disease and Multiple System Atrophy. Mov. Disord. 37, 1059\u20131063 (2022).","journal-title":"Mov. Disord."},{"key":"48093_CR15","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/brain\/awab005","volume":"144","author":"A Stefani","year":"2021","unstructured":"Stefani, A. et al. Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. Brain 144, 1118\u20131126 (2021).","journal-title":"Brain"},{"key":"48093_CR16","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mds.26463","volume":"31","author":"Y Saito","year":"2016","unstructured":"Saito, Y. et al. Lewy body pathology involves the olfactory cells in Parkinson\u2019s disease and related disorders. Mov. Disord. 31, 135\u2013138 (2016).","journal-title":"Mov. Disord."},{"key":"48093_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/mds.22464","volume":"24","author":"M Witt","year":"2009","unstructured":"Witt, M. et al. Biopsies of olfactory epithelium in patients with Parkinson\u2019s disease. Mov. Disord. 24, 906\u2013914 (2009).","journal-title":"Mov. Disord."},{"key":"48093_CR18","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1093\/brain\/awac115","volume":"145","author":"A Kluge","year":"2022","unstructured":"Kluge, A. et al. Detection of neuron-derived pathological \u03b1-synuclein in blood. Brain 145, 3058\u20133071 (2022).","journal-title":"Brain"},{"key":"48093_CR19","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/ana.26917","volume":"95","author":"A Kluge","year":"2024","unstructured":"Kluge, A. et al. \u03b1-Synuclein Pathology in PRKN\u2010Linked Parkinson\u2019s Disease: New Insights from a Blood\u2010Based Seed Amplification Assay. Ann. Neurol. 95, 1173\u20131177 (2024).","journal-title":"Ann. Neurol."},{"key":"48093_CR20","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/mds.29766","volume":"39","author":"A Kluge","year":"2024","unstructured":"Kluge, A. et al. Detecting Misfolded \u03b1-Synuclein in Blood Years before the Diagnosis of Parkinson\u2019s Disease. Mov. Disord. 39, 1289\u20131299 (2024).","journal-title":"Mov. Disord."},{"key":"48093_CR21","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/mds.27423","volume":"33","author":"G Vivacqua","year":"2018","unstructured":"Vivacqua, G., Mancinelli, R., Belvisi, D., Suppa, A. & Berardelli, A. Detection of \u03b1-Synuclein in Saliva: The Importance of Preanalytical Assessment. Mov. Disord. 33, 1029\u20131030 (2018).","journal-title":"Mov. Disord."},{"key":"48093_CR22","doi-asserted-by":"crossref","unstructured":"Maass, F. et al. Increased alpha-synuclein tear fluid levels in patients with Parkinson\u2019s disease. Scientific Reports 10, (2020).","DOI":"10.1038\/s41598-020-65503-1"},{"key":"48093_CR23","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ajpath.2020.03.001","volume":"190","author":"K Dias-Teixeira","year":"2020","unstructured":"Dias-Teixeira, K. Lacrimal Gland Postganglionic Innervation. Am. J. Pathol. 190, 968\u2013969 (2020).","journal-title":"Am. J. Pathol."},{"key":"48093_CR24","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1212\/WNL.0000000000000204","volume":"82","author":"CH Adler","year":"2014","unstructured":"Adler, C. H. et al. Submandibular gland needle biopsy for the diagnosis of Parkinson disease. Neurology 82, 858\u2013864 (2014).","journal-title":"Neurology"},{"key":"48093_CR25","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/mds.26476","volume":"31","author":"CH Adler","year":"2016","unstructured":"Adler, C. H. et al. Peripheral Synucleinopathy in Early Parkinson\u2019s Disease: Submandibular Gland Needle Biopsy Findings. Mov. Disord. 31, 250\u2013256 (2016).","journal-title":"Mov. Disord."},{"key":"48093_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-026-01282-2","author":"S Canaslan","year":"2026","unstructured":"Canaslan, S. et al. Detection of alpha-synuclein seeding activity in tear fluid in patients with Parkinson\u2019s disease. npj Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-026-01282-2 (2026).","journal-title":"npj Parkinsons Dis."},{"key":"48093_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1212\/WNL.50.2.318","volume":"50","author":"MM Hoehn","year":"1998","unstructured":"Hoehn, M. M. & Yahr, M. D. Parkinsonism: Onset, progression, and mortality. Neurology 50, 318\u2013318 (1998).","journal-title":"Neurology"},{"key":"48093_CR28","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s10072-012-1112-z","volume":"34","author":"MDS-UPDRS Italian Validation Study Group","year":"2013","unstructured":"MDS-UPDRS Italian Validation Study Group. Validation of the Italian version of the Movement Disorder Society\u2014Unified Parkinson\u2019s Disease Rating Scale. Neurol. Sci. 34, 683\u2013687 (2013).","journal-title":"Neurol. Sci."},{"key":"48093_CR29","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.parkreldis.2016.10.020","volume":"34","author":"I Cova","year":"2017","unstructured":"Cova, I. et al. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson\u2019s disease. Parkinsonism Relat. Disord. 34, 38\u201342 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"48093_CR30","first-page":"8","volume":"25","author":"L Kurlowicz","year":"1999","unstructured":"Kurlowicz, L. & Wallace, M. The Mini-Mental State Examination (MMSE). J. Gerontol. Nurs. 25, 8\u20139 (1999).","journal-title":"J. Gerontol. Nurs."},{"key":"48093_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine, Z. S. et al. The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment. J. Am. Geriatr. Soc. 53, 695\u2013699 (2005).","journal-title":"J. Am. Geriatr. Soc."},{"key":"48093_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00702-023-02624-7","volume":"130","author":"EN Aiello","year":"2023","unstructured":"Aiello, E. N. et al. Clinimetrics and feasibility of the Italian version of the Frontal Assessment Battery (FAB) in non-demented Parkinson\u2019s disease patients. J. Neural Transm. 130, 687\u2013696 (2023).","journal-title":"J. Neural Transm"},{"key":"48093_CR33","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s10072-007-0791-3","volume":"28","author":"A Alberici","year":"2007","unstructured":"Alberici, A. et al. The Frontal Behavioural Inventory (Italian version) differentiates frontotemporal lobar degeneration variants from Alzheimer\u2019s disease. Neurol. Sci. 28, 80\u201386 (2007).","journal-title":"Neurol. Sci."},{"key":"48093_CR34","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster, K. et al. The REM sleep behavior disorder screening questionnaire\u2014A new diagnostic instrument. Mov. Disord. 22, 2386\u20132393 (2007).","journal-title":"Mov. Disord."},{"key":"48093_CR35","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1056\/NEJMc2214647","volume":"388","author":"M Schmitz","year":"2023","unstructured":"Schmitz, M. et al. Detection of Prion Protein Seeding Activity in Tear Fluids. N Engl. J. Med. 388, 1816\u20131817 (2023).","journal-title":"N Engl. J. Med."},{"key":"48093_CR36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-025-02212-8","volume":"14","author":"SDS Correia","year":"2026","unstructured":"Correia, S. D. S. et al. Advancing prion diagnostics: full-length human E200K RT-QuIC substrate facilitates prion detection in tear fluid and improves sensitivity in cerebrospinal fluid. acta neuropathol. commun. 14, 28 (2026).","journal-title":"acta neuropathol. commun."},{"key":"48093_CR37","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi, M. et al. Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol. 140, 49\u201362 (2020).","journal-title":"Acta Neuropathol."},{"key":"48093_CR38","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1002\/mds.30085","volume":"40","author":"P Grillo","year":"2025","unstructured":"Grillo, P., Concha-Marambio, L., Pisani, A., Riboldi, G. M. & Kang, U. J. Association between the Amplification Parameters of the \u03b1\u2010Synuclein Seed Amplification Assay and Clinical and Genetic Subtypes of Parkinson\u2019s Disease. Mov. Disord. 40, 305\u2013314 (2025).","journal-title":"Mov. Disord."},{"key":"48093_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"48093_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s40478-021-01282-8","volume":"9","author":"MJ Russo","year":"2021","unstructured":"Russo, M. J. et al. High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson\u2019s disease. acta neuropathol. commun. 9, 179 (2021).","journal-title":"acta neuropathol. commun."},{"key":"48093_CR41","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1002\/acn3.51753","volume":"10","author":"LM Chahine","year":"2023","unstructured":"Chahine, L. M. et al. Central and peripheral \u03b1-synuclein in Parkinson disease detected by seed amplification assay. Ann. Clin. Transl. Neurol. 10, 696\u2013705 (2023).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"48093_CR42","doi-asserted-by":"crossref","unstructured":"Mastrangelo, A. et al. Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants. Acta Neuropathol 149, (2025).","DOI":"10.1007\/s00401-025-02904-4"},{"key":"48093_CR43","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.dadm.2018.06.005","volume":"10","author":"N Kruse","year":"2018","unstructured":"Kruse, N. et al. Interlaboratory validation of cerebrospinal fluid \u03b1-synuclein quantification in the diagnosis of sporadic Creutzfeldt\u2010Jakob disease. Alz Dem Diag Ass Dis. Mo. 10, 461\u2013470 (2018).","journal-title":"Alz Dem Diag Ass Dis. Mo"},{"key":"48093_CR44","doi-asserted-by":"publisher","first-page":"e70205","DOI":"10.1002\/alz.70205","volume":"21","author":"EM Jonaitis","year":"2025","unstructured":"Jonaitis, E. M. et al. Misfolded \u03b1-synuclein co\u2010occurrence with Alzheimer\u2019s disease proteinopathy. Alzheimer\u2019s Dement. 21, e70205 (2025).","journal-title":"Alzheimer\u2019s Dement."},{"key":"48093_CR45","doi-asserted-by":"publisher","first-page":"7624","DOI":"10.1002\/alz.14225","volume":"20","author":"A Pichet Binette","year":"2024","unstructured":"Pichet Binette, A. et al. Associations between misfolded alpha-synuclein aggregates and Alzheimer\u2019s disease pathology in vivo. Alzheimer\u2019s Dement. 20, 7624\u20137634 (2024).","journal-title":"Alzheimer\u2019s Dement."},{"key":"48093_CR46","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/mds.29329","volume":"38","author":"L Concha-Marambio","year":"2023","unstructured":"Concha-Marambio, L. et al. Accurate Detection of \u03b1\u2010Synuclein Seeds in Cerebrospinal Fluid from Isolated Rapid Eye Movement Sleep Behavior Disorder and Patients with Parkinson\u2019s Disease in the DeNovo Parkinson (DeNoPa) Cohort. Mov. Disord. 38, 567\u2013578 (2023).","journal-title":"Mov. Disord."},{"key":"48093_CR47","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/brain\/awab431","volume":"145","author":"I Poggiolini","year":"2022","unstructured":"Poggiolini, I. et al. Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies. Brain 145, 584\u2013595 (2022).","journal-title":"Brain"},{"key":"48093_CR48","doi-asserted-by":"crossref","unstructured":"De Luca, C. M. G. et al. Efficient RT-QuIC seeding activity for \u03b1-synuclein in olfactory mucosa samples of patients with Parkinson\u2019s disease and multiple system atrophy. Translational Neurodegeneration 8, (2019).","DOI":"10.1186\/s40035-019-0164-x"},{"key":"48093_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s00401-010-0665-2","volume":"119","author":"K Del Tredici","year":"2010","unstructured":"Del Tredici, K., Hawkes, C. H., Ghebremedhin, E. & Braak, H. Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson\u2019s disease. Acta Neuropathol. 119, 703\u2013713 (2010).","journal-title":"Acta Neuropathol."},{"key":"48093_CR50","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s00401-016-1538-0","volume":"131","author":"M Brahic","year":"2016","unstructured":"Brahic, M., Bousset, L., Bieri, G., Melki, R. & Gitler, A. D. Axonal transport and secretion of fibrillar forms of \u03b1-synuclein, A\u03b242 peptide and HTTExon 1. Acta Neuropathol. 131, 539\u2013548 (2016).","journal-title":"Acta Neuropathol."},{"key":"48093_CR51","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1096\/fj.10-164624","volume":"25","author":"KM Danzer","year":"2011","unstructured":"Danzer, K. M. et al. Heat-shock protein 70 modulates toxic extracellular \u03b1\u2010synuclein oligomers and rescues trans\u2010synaptic toxicity. FASEB j. 25, 326\u2013336 (2011).","journal-title":"FASEB j."},{"key":"48093_CR52","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt, E. C. et al. Neuron-to\u2010neuron transmission of \u03b1\u2010synuclein fibrils through axonal transport. Ann. Neurol. 72, 517\u2013524 (2012).","journal-title":"Ann. Neurol."},{"key":"48093_CR53","doi-asserted-by":"publisher","unstructured":"Zheng, Y. et al. Detection of \u03b1-Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder. Movement Disorders mds. 29828 https:\/\/doi.org\/10.1002\/mds.29828 (2024).","DOI":"10.1002\/mds.29828"},{"key":"48093_CR54","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/s41598-023-28363-z","volume":"13","author":"M Gijs","year":"2023","unstructured":"Gijs, M. et al. Pre-analytical sample handling effects on tear fluid protein levels. Sci. Rep. 13, 1317 (2023).","journal-title":"Sci. Rep."},{"key":"48093_CR55","doi-asserted-by":"publisher","unstructured":"Orr\u00fa, C. D. et al. B. Factors That Improve RT-QuIC Detection of Prion Seeding Activity. Viruses. 8(5), 140 (2016). https:\/\/doi.org\/10.3390\/v8050140","DOI":"10.3390\/v8050140"},{"key":"48093_CR56","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3867","author":"K Xiao","year":"2018","unstructured":"Xiao, K. et al. Evaluation of the effect of various main elements on the PrPSc detection by real-time quaking-induced conversion assay. Int. J. Mol. Med. https:\/\/doi.org\/10.3892\/ijmm.2018.3867 (2018).","journal-title":"Int. J. Mol. Med."},{"key":"48093_CR57","doi-asserted-by":"crossref","unstructured":"Orr\u00fa, C. D. et al. Prion Disease Blood Test Using Immunoprecipitation and Improved Quaking-Induced Conversion. mBio 2, e00078-11 (2011).","DOI":"10.1128\/mBio.00078-11"},{"key":"48093_CR58","doi-asserted-by":"publisher","first-page":"eadt7195","DOI":"10.1126\/sciadv.adt7195","volume":"11","author":"HA Lashuel","year":"2025","unstructured":"Lashuel, H. A. et al. Alpha-synuclein seed amplification assays: Data sharing, standardization needed for clinical use. Sci. Adv. 11, eadt7195 (2025).","journal-title":"Sci. Adv."},{"key":"48093_CR59","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1002\/mds.27362","volume":"33","author":"RB Postuma","year":"2018","unstructured":"Postuma, R. B. et al. Validation of the MDS clinical diagnostic criteria for Parkinson\u2019s disease. Mov. Disord. 33, 1601\u20131608 (2018).","journal-title":"Mov. Disord."},{"key":"48093_CR60","doi-asserted-by":"publisher","unstructured":"Kuzkina, A. et al. K. Combining skin and olfactory \u03b1-synuclein seed amplification assays (SAA)-towards biomarker-driven phenotyping in synucleinopathies. NPJ. Parkinsons. Dis. 9(1), 79 (2023). https:\/\/doi.org\/10.1038\/s41531-023-00519-8.","DOI":"10.1038\/s41531-023-00519-8"},{"key":"48093_CR61","doi-asserted-by":"publisher","unstructured":"Bargar, C. et al. F. Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories. Mol. Neurodegener. 16(1), 82 (2021).https:\/\/doi.org\/10.1186\/s13024-021-00491-y.","DOI":"10.1186\/s13024-021-00491-y"},{"key":"48093_CR62","doi-asserted-by":"publisher","first-page":"105626","DOI":"10.1016\/j.nbd.2022.105626","volume":"164","author":"J Horsager","year":"2022","unstructured":"Horsager, J., Knudsen, K. & Sommerauer, M. Clinical and imaging evidence of brain-first and body-first Parkinson\u2019s disease. Neurobiol. Dis. 164, 105626 (2022).","journal-title":"Neurobiol. Dis."},{"key":"48093_CR63","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.parkreldis.2024.106101","volume":"122","author":"J Horsager","year":"2024","unstructured":"Horsager, J. & Borghammer, P. Brain-first vs. body-first Parkinson\u2019s disease: An update on recent evidence. Parkinsonism Relat. Disord. 122, 106101 (2024).","journal-title":"Parkinsonism Relat. Disord."},{"key":"48093_CR64","doi-asserted-by":"crossref","unstructured":"Borghammer, P. & Van Den Berge, N. Brain-First versus Gut-First Parkinson\u2019s Disease: A Hypothesis. Journal Parkinson\u2019s Disease 9, (2019).","DOI":"10.3233\/JPD-191721"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48093-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48093-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T01:01:58Z","timestamp":1779670918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-48093-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["48093"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-48093-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"assertion":[{"value":"27 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the national ethics committee (n. 0059845) and conducted according to the Declaration of Helsinki principles. All patients were informed of the purpose of the study and.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"16118"}}